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Abstract
Acinetobacter species are well-known causes of nosocomial infections. Recent increasing evidence
emphasize on the role of these pathogens in community-acquired infections.
We report a case of a 16-yr-old female with fever, sore throat, productive cough, malaise and the
presence of lung consolidation with multiple abscesses on radiographic examination. The patient
had no significant medical history. After a detailed diagnostic work-up the diagnosis of community
acquired Acinetobacter pneumonia with multiple lung abscesses was made. The Acinetobacter
stain was susceptible to a variety of antimicrobial agents and the patient's condition improved
rapidly. A new computed tomography chest scan, three months later, confirmed full recovery.
The presence of lung abscesses due to Acinetobacter infection is an extremely uncommon
manifestation of the disease. This case underlines the emergent role which these, often multi-drug
resistant, bacteria may play in the future, perhaps in community infections as well.
Case presentation
A 16-yr-old female presented to the emergency depart-
ment with a two-day history of fever up to 39°C, sore
throat, productive cough and malaise. Initially a diagnosis
of acute tonsillitis was made and the patient was treated
for a seven-day period with penicillin. Unfortunately the
patient remained febrile up to 38°C, with persistent pro-
ductive cough and malaise. Ten days after her first visit she
was admitted to the pulmonary department for further
evaluation. The patient until then had no significant med-
ical history.
On admission she had low-grade fever (37,4°C). The rest
of the clinical findings were unremarkable. Blood tests
demonstrated normal white cell count (9500/μl), anemia
(hematocrit 32,6% and hemoglobin 10,7 gr/dl), mild
thrombocytosis (512000/μl), increased erythrocyte sedi-
mentation rate (ESR = 109 mm/hr) and C-reactive protein
(CRP = 49,6 mg/dl). Serum biochemistry tests were within
normal limits. Arterial blood gases were normal as well.
The chest radiograph disclosed a right upper lobe consol-
idation with the presence of at least three abscesses within
the lobe. A spiral computed tomography of the chest dem-
onstrated the consolidation within the right upper lobe
with multiple lung abscesses (Figure 1). No other evi-
dence of parechymal damage, lymph nodes enlargement
or pleural fluid was visible. Heart and great vessels visual-
ized without any pathology.
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Cardiological examination including heart ultrasono-
graphic analysis and dental examination did not demon-
strate any pathological evidence. Skin tests for M.
tuberculosis, atypical mycobacteria and Quanti-FERON
TB Gold test were negative. Serum component analysis,
rheumatoid factor, antinuclear antibodies, antineu-
trophilic cytoplasmic antibodies, immunonoglobin lev-
els, serologic tests for hepatitis A, B, C, D, human
immunodeficiency virus and common viruses did not
reveal any abnormality. Finally sputum cultures in three
different samples revealed the presence of Acinetobacter
baumannii and the diagnosis of community-acquired
pneumonia with multiple abscesses due to Acinetobacter
baumannii infection were made based on this evidence.
The stains were susceptible to multiple antibiotics and
treatment with ciprofloxacin and amoxicillin with clavou-
lanic acid was initiated for a three month period of treat-
ment. A significant clinical improvement in the patient's
condition was noted only a few days later which was
reflected in her laboratory investigation as well. Three
months later a new computed tomography scan of the
chest was obtained revealing an almost completely healed
right upper lobe (Figure 2). The patient remains asympto-
matic until now.
Discussion
Acinetobacter spp are aerobic gram-negative coccobacillus
with preference for warm, ambient environments, which
have received a great interest during the last two decades
due to its ability to accumulate, with multiple mecha-
nisms, multi-drug resistance stains. As a result these bacte-
ria have become, a sometimes lethal, etiologic factor
mainly in intensive care unit (ICU) infections, ventilator
associated pneumonia (VAP), and in community-
acquired infections and represent an emergent public
health problem [1,2].
Typically this pathogen has been described as a cause of
infection in tropical or subtropical climates, more often
during summer, in ICU patients or in long term residents
at health care facilities. Ventilator-depended patients are
at greater risk but other factors such as recent surgery, cen-
tral vascular lines, tracheotomy, enteral feeding and treat-
ment with new generation antibiotics, like third-
generation cephalosporins, fluoroquinolones or carbap-
enems, may contribute as well. The majority of affected
patients have underlying comorbidities mainly chronic
obstructive pulmonary disease, renal disease, diabetes
mellitus, alcoholism and heavy smoking [1,3,4].
Nosocomial outbreaks have also been described due to
health care professionals with colonized hands and poor
personal hygiene. These people could act as opportunist
carriers of an epidemic stain. Contaminated ventilators or
respiratory care equipment as well as intrahospital trans-
mission may also contribute to the beginning of an out-
break [1,4].
The computed tomography scan of this 16-y- old female  revealed the presence of multiple abscesses at the right  upper lobe Figure 1
The computed tomography scan of this 16-y- old 
female revealed the presence of multiple abscesses 
at the right upper lobe.
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Recently Turkey's earthquakes in Marmara area, as well as
others physical disasters like the South Asia tsunami,
demonstrated that vulnerable populations are also at risk
to Acinetobacter infections due to contamination and
cross-infection inside hospital settings [1]. Moreover as a
result of the ongoing war conflicts in Afghanistan and Iraq
some cases of multi-drug resistant Acinetobacter out-
breaks have also been reported bringing reminiscent of
similar reports during the Korean and Vietnam wars. It
seems that in cases like these multiple factors can contrib-
ute including contamination of wounds in the battlefield,
local food, environmental spread and cross-infection in
the local military or abroad hospitals [5].
Community-acquired infections due to these pathogens
are still rarely reported, mainly in warm and humid cli-
mates, and pneumonia. Fulminant course with an acute
onset of dyspnea, cough, and fever, is the most common
manifestation. Most patients suffer from various comor-
bidities. Leung et al in a three- year retroprospective study
involving 19 patients with community-acquired pneumo-
nia (CAP) due to Acinetobacter baumannii and 74
patients with health care associated pneumonia (HAP)
concluded that CAP appears to be a unique clinical entity
with a high incidence of bacteremia, ARDS, disseminated
intravascular coagulation (DIC), and death, when com-
pared to HAP [6]. In another study involving thirteen
patients Chen et al concluded that Acinetobacter bauman-
nii can be considered as an etiologic factor in community-
acquired lobar pneumonia in patients with fulminant
course in the warmer and humid periods of the year and
also in younger alcoholic patients. The authors also sug-
gested that a good sputum smear originated from the
lower respiratory tract if it contains >25 leukocytes per
high power (100×) field on microscopic examination
early on to establish the diagnosis and that a combination
of a third-generation cephalosporin and an aminoglyco-
side is adequate as empirical treatment [7]. Falagas et al in
a recent review highlighted six case series with commu-
nity-acquired Acinetobacter infections involving 80
patients. Of these 51 had pneumonia and 56% (45
patients) died. Moreover in the same review 26 case
reports involving 43 patients had been identified. Pneu-
monia was present in 38 of them and from the others two
had meningitis, one had native valve endocarditis, one
had soft skin infection and one had an ocular infection.
Chronic obstructive pulmonary disease, renal disease, dia-
betes mellitus, excess consumption of alcohol and heavy
smoking were the most common risk factors. According to
the same review on 12 retrospective or prospective studies
the range of isolation of Acinetobacter from patients suf-
fering from community-acquired pneumonia was 1, 3%
to 25, 9% [8].
A variety of antibiotics can be used if the infection has
been caused by a susceptible stain including broad-spec-
trum cephalosporins, β-lactam-β-lactamase inhibitor
combinations, carbapenes, and fluoroquinolones alone
or in combination with aminoglycosides. Multi-drug
resistant infections, including carbapenes, aminoglyco-
sides and fluoroquinolones resistance, are challenging,
however the combination of intravenous or inhaled colis-
tin with tigercycline, imipenem, rifampicin or azithromy-
cin seems reasonably enough to achieve satisfactory
efficiency, at least in vitro, due to synergic or addictive
effects which these combinations offer. On the other hand
it's unclear if these antibiotic combinations provide ade-
quate therapeutically results in vivo [1,2,9,10].
To our knowledge only three other cases of lung abscesses
and three more of pneumatoceles due to Acinetobacter
infection that have been described until now but none has
been presented with multiple abscesses on admission.
Myrianthefs et al reported a case of a 77-year old woman
with multi-drug resistant Acinetobacter baumannii lung
abscesses who underwent splenectomy after multiple
traumas and remained for a long period in an ICU. Fortu-
nately this patient recovered [11]. Hunt et al reported
three cases of ICU pneumonia with the formation of
pneumatoceles due to Acinetobacter infection. Unfortu-
nately none of them survived [12]. Yen et al in a 23 cases
retrospective review of pediatric lung abscesses reported
only one case of secondary abscess due to Acinetobacter
baumannii infection. Although only two deaths occurred
in this group of patients it's unclear if one of them was the
Acinetobacter baumannii infected patient [13]. Finally
Yang et al reported a case of a 35-year-old male with right
lobe necrotizing community-acquired pneumonia and
lung abscess formation one week after his admission, who
achieved a slow but fully recovery [14].
In conclusion we presented a case of right lobe commu-
nity acquired pneumonia with the formation of multiple
lung abscesses due to a susceptible Acinetobacter bau-
mannii stain. This is a rare manifestation of a community
acquired disease.
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